| May 18, 2026 | Blue Shield of California | Kidney TransplantPayerPolicy · BSCA-Kidney-Transplant | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | KeratoprosthesisPayerPolicy · BSCA-Keratoprosthesis | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney, Lung or ProstatePayerPolicy · BSCA-Irreversible-Electroporation-Tumors-Liver-Pancreas-Kidney-Lung | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Investigational ServicesPayerPolicy · BSCA-Investigational-Services | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Interventions for Progressive ScoliosisPayerPolicy · BSCA-Interventions-Progressive-Scoliosis | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Injectable Bulking Agents for the Treatment of Urinary and Fecal IncontinencePayerPolicy · BSCA-Injectable-Bulking-Agents-TX-Urinary-Fecal-Incontinence | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Inhaled Nitric OxidePayerPolicy · BSCA-Inhaled-Nitric-Oxide | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Implantable Bone-Conduction and Bone-Anchored Hearing AidsPayerPolicy · BSCA-Implantable-Bone-Conduction-Bone-Anchored-Hearing-Aids | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hysterectomy Surgery for Benign ConditionsPayerPolicy · BSCA-Hysterectomy-Surgery-Benign-Conditions | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic MalignanciesPayerPolicy · BSCA-Hyperthermic-Intraperitoneal-Chemo-Intra-Abdominal-Pelvic-Malignancies | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Home Cardiorespiratory MonitoringPayerPolicy · BSCA-Home-Cardiorespiratory-Monitoring | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hip ResurfacingPayerPolicy · BSCA-Hip-Resurfacing | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation in the Treatment of Germ Cell TumorsPayerPolicy · BSCA-HCT-Treatment-Germ-Cell-Tumors | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodPayerPolicy · BSCA-HCT-Solid-Tumors-Childhood | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · BSCA-HCT-Primary-Amyloidosis | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · BSCA-HCT-Plasma-Cell-Dyscrasias-Including-Multiple-Myeloma-POEMS-Syndrome | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · BSCA-HCT-Hodgkin-Lymphoma | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · BSCA-HCT-Chronic-Myeloid-Leukemia | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPayerPolicy · BSCA-HCT-Chronic-Lymphocytic-Leukemia-Small-Lymphocytic-Lymphoma | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaPayerPolicy · BSCA-HCT-Central-Nervous-System-Embryonal-Tumors-Ependymoma | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · BSCA-HCT-Autoimmune-Diseases | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · BSCA-HCT-Acute-Myeloid-Leukemia | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · BSCA-HCT-Acute-Lymphoblastic-Leukemia | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Heart/Lung TransplantPayerPolicy · BSCA-Heart-Lung-Transplant | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Heart TransplantPayerPolicy · BSCA-Heart-Transplant | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · BSCA-Germline-Genetic-Test-Breast-Ovarian-Cancer-BRCA1-BRCA2-PALB2 | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for the Diagnosis of Inherited Peripheral NeuropathiesPayerPolicy · BSCA-Genetic-Testing-Dx-Inherited-Peripheral-Neuropathies | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Mitochondrial DisordersPayerPolicy · BSCA-Genetic-Testing-Mitochondrial-Disorders | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related DisordersPayerPolicy · BSCA-Genetic-Test-Marfan-Syndrome-Thoracic-Aneurysms-Dissections | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BSCA-Genetic-Testing-Lynch-Syndrome-Inherited-Colon-Cancer-Syndromes | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Diagnosis and Management of Mental Health ConditionsPayerPolicy · BSCA-Genetic-Testing-Dx-Management-Mental-Health-Conditions | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · BSCA-Genetic-Testing-Cardiac-Ion-Channelopathies | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Testing for Alzheimer DiseasePayerPolicy · BSCA-Genetic-Testing-Alzheimer-Disease | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Cancer Susceptibility Panels Using Next-Generation SequencingPayerPolicy · BSCA-Genetic-Cancer-Susceptibility-Panels-Using-Next-Gen-Sequencing | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Genetic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Advanced CancerPayerPolicy · BSCA-Genetic-Biomarker-Testing-TX-Advanced-Cancer | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Fecal Microbiota TransplantationPayerPolicy · BSCA-Fecal-Microbiota-Transplantation | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Fecal Calprotectin TestingPayerPolicy · BSCA-Fecal-Calprotectin-Testing | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Extracranial Carotid Artery StentingPayerPolicy · BSCA-Extracranial-Carotid-Artery-Stenting | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Extracorporeal PhotopheresisPayerPolicy · BSCA-Extracorporeal-Photopheresis | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Extracorporeal Membrane Oxygenation for Adult ConditionsPayerPolicy · BSCA-Extracorporeal-Membrane-Oxygenation-Adult-Conditions | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Esophageal pH MonitoringPayerPolicy · BSCA-Esophageal-pH-Monitor | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Enhanced External CounterpulsationPayerPolicy · BSCA-Enhanced-External-Counterpulsation | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Endovascular Stent Grafts for Disorders of the Thoracic AortaPayerPolicy · BSCA-Endovascular-Stent-Grafts-Disorders-Thoracic-Aorta | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Endovascular Stent Grafts for Abdominal Aortic AneurysmsPayerPolicy · BSCA-Endovascular-Stent-Grafts-Abdominal-Aortic-Aneurysms | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Endobronchial Ultrasound for Diagnosis and Staging of Lung CancerPayerPolicy · BSCA-Endobronchial-Ultrasound-DX-Lung-Cancer | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Electromyography and Nerve Conduction StudiesPayerPolicy · BSCA-Electromyography-Conduction-Studies | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Electromagnetic Navigational BronchoscopyPayerPolicy · BSCA-Electromagnetic-Nav-Bronchoscopy | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Electrical Bone Growth Stimulation of the Appendicular SkeletonPayerPolicy · BSCA-Electrical-Bone-Stimulation-Appendicular-Skeleton | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Drug Testing in Pain Management and Substance Use Disorder TreatmentPayerPolicy · BSCA-Drug-Test-Substance-Abuse-TX | Criteria changed |
|---|
| May 18, 2026 | Blue Shield of California | Diagnosis of Obstructive Sleep Apnea SyndromePayerPolicy · BSCA-DX-OSA-Syndrome | Criteria changed |
|---|